Death rate increases by up to a quarter among septic shock patients with sarcopenia, Severance Hospital said Friday.Infectious disease Professors Ku Nam-su and Kim Jung-ho announced that the mortality rate of septic shock patients with sarcopenia increased by up to 26.5 percent.There have been consi
Biosensor company i-SENS signed a memorandum of understanding with Meraki Place, a digital healthcare provider, to develop a chronic disease management service on Wednesday.Meraki Place runs a non-face-to-face medical treatment platform, My Doctor, and provides a one-stop service from treatment and
The medical staff of Korea University Ansan Hospital (KUAH) provided medical assistance to ethnic Koreans who had evacuated to their fatherland because of Russia’s war in Ukraine.About 30 medical workers offered medical services at the foreign residents’ support center in Ansan, Gyeonggi Province, f
Local researchers have developed and proved the accuracy of a technology that can decipher the eyelid’s meibomian gland image using artificial intelligence.In the past, ophthalmologists measured meiboscore in degrees, a subjective reading method that lacks accuracy and reproducibility.Breaking away
Professor Song Kyoung-ho of the Department of Infectious Disease at Seoul National University Bundang Hospital has been appointed an editor of Scientific Reports, an international academic journal.Scientific Reports is an online, open-access journal published by the Nature Publishing Group and a sis
T&R Biofab said Wednesday that it signed a strategic joint development agreement with Johnson & Johnson Innovation to develop the 3D bio-printing scaffold technology.According to T&R Biofab, the contract’s purpose is to develop an implantable product in the body based on diverse biomaterials and bio
Icure Pharmaceutical, a company specializing in drug delivery systems, has set about to expand oral incrementally modified drug (IMD) pipelines.The company said Wednesday that it had signed a technology transfer agreement with Hanall Biopharma on IMD for gastroesophageal reflux disease (GERD). Under
Idience said Tuesday that venadaparib, the company’s novel drug candidate for targeted agents, has been designated as an orphan drug by the U.S. Food and Drug Administration.Idience is a subsidiary of Ildong Holdings, the holding company of Ildong Pharmaceutical Group, specializing in novel drug dev
MiCo BioMed, an in-vitro diagnostic medical device maker, said Tuesday that it completed the clinical trial of the monkeypox testing kit and applied for its export approval to the Ministry of Food and Drug Safety (MFDS).In July, the company conducted a clinical trial of a monkeypox PCR testing kit (
SK Biopharmaceuticals’ epilepsy drug Cenobamate will soon be reviewed for approval in Canada and Israel.Paladin Labs, a subsidiary of SK Biopharma’s partner company Endo International, sent new drug submission (NDS) for the innovative novel drug for epilepsy to Health Canada in June.If the Canadian
Pangen Biotech announced Monday that it signed a joint development agreement with Moogene Medi to develop a protein treatment using lipid nanoparticles (LNPs).The two companies also applied for a patent on “LNPs for protein transfer” in July.LNPs are transmitter substances of mRNA Covid-19 vaccine d
MedPacto announced Monday that it received green light from the U.S. FDA to test Vactosertib as a solo therapy for recurrent and intractable osteosarcoma patients in a phase 1/2 trial.The study will be on 54 patients aged 14 or older who suffer from recurrent or intractable osteosarcoma and carried
HLB Life Science, which owns rights to market Jiangsu Hengrui Medicine’s anticancer drug pyrotinib in Korea, said it would expand new pipelines on the back of the recent success of a phase 3 pyrotinib trial.Jiangsu Hengrui announced that the phase 3 clinical trial of pyrotinib met the primary endpoi
SillaJen announced Thursday that it tapped Kim Jae-kyung, a former head of LabGenomics, as the new CEO.With Kim taking the helm, SillaJen said it would be able to normalize stock trading and strengthen corporate transparency.Kim was a founding member and CEO of LabGenomics. He also served as an adju
Bridge Biotherapeutics announced that it would release non-clinical data of idiopathic pulmonary fibrosis (IPF) treatment candidates BBT-301 and BBT-209 at the IPF summit 2022 to be held at Boston from Aug. 29 to Sept. 1.According to the company, BBT-301 is a novel drug candidate which fights the di
Myongji Hospital said it introduced a surgical robot 'CUVIS joint' to increase the precision of joint replacement surgery.Developed by Curexo, a local firm, CUVIS joint automatizes the entire bone cutting process, required before a joint replacement surgery, the hospital said.The surgical robot is e
Reyon Pharmaceutical said it would expand business partnerships at the Bioplus-Interphex Korea 2022, Korea’s largest biotech convention held at COEX, Seoul.At the BIX 2022, Reyon Pharmaceutical will seek partners for co-development and CDMO/CMO business by promoting its cGMP biologic drug factory lo
Korean researchers said they found the clinical and immunological effects of Covid-19 in severe asthma patients.The research team, led by Professor Lee Yong-chul and Jeong Jae-seok at the Research Center for Pulmonary Disorders of Jeonbuk National University Hospital, published the study in the onli
GC Biopharma announced on Monday that operating profit for the second quarter of 2022 jumped by 18 percent on year recording 13.1 billion won ($10 million).Sales stood at 423.2 billion won in the second quarter, up 9.2 percent year-on-year. Net profit jumped 45.3 percent to 10.9 billion won in the s
Samjin Pharmaceutical signed an agreement with Cyclica, a Canadian AI-based novel drug development platform company, for a joint research on AI novel drug development.Under the agreement, Samjin Pharmaceutical will propose several potential drug candidates to Cyclica, and Cyclica will apply its AI-b